Cargando…
The Progress of Label-Free Optical Imaging in Alzheimer’s Disease Screening and Diagnosis
As the major neurodegenerative disease of dementia, Alzheimer’s disease (AD) has caused an enormous social and economic burden on society. Currently, AD has neither clear pathogenesis nor effective treatments. Positron emission tomography (PET) and magnetic resonance imaging (MRI) have been verified...
Autores principales: | Liu, Kai, Li, Jiasong, Raghunathan, Raksha, Zhao, Hong, Li, Xuping, Wong, Stephen T. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341907/ https://www.ncbi.nlm.nih.gov/pubmed/34366828 http://dx.doi.org/10.3389/fnagi.2021.699024 |
Ejemplares similares
-
Label-free optical metabolic imaging of adipose tissues for prediabetes diagnosis
por: Chen, Liping, et al.
Publicado: (2023) -
Revealing architectural order with quantitative label-free imaging and deep learning
por: Guo, Syuan-Ming, et al.
Publicado: (2020) -
Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression
por: Javaid, Fatimah Zara, et al.
Publicado: (2016) -
Label-free optical quantification of structural alterations in Alzheimer’s disease
por: Lee, Moosung, et al.
Publicado: (2016) -
Label-free multimodal nonlinear optical imaging of needle biopsy cores for intraoperative cancer diagnosis
por: Yang, Lingxiao, et al.
Publicado: (2022)